TIKTOK
6.9.2018 12:57:28 CEST | Business Wire | Press release
TikTok, the go-to destination for the creating and viewing short-term mobile videos, has arrived in the global capital of fashion: Paris. The worldwide phenomenon held its first event on Tuesday September 4 during a unique night on the Seine. With its “80’s vs 2080 theme, TikTok took its community on a creative and innovative adventure, like its platform. The brand also welcomed today’s most creative influencers to celebrate the arrival of the new TikTok platform, born from the union with the Musical.ly app, and has thus unveiled application’s new innovative features and technological innovations of the application, such as "reaction" function that allows users to react directly to their friends' videos.
TikTok : a new groundbreaking upgrade
A global platform now
present in more than 150 countries and regions, TikTok was one of the
most downloaded applications in the world in early 20181
. The
latest update, which incorporates the best of both applications, has
allowed TikTok to creatively connect its community in a multicultural
environment. The newly upgraded platform, offers greater capabilities
for video creation and allows creators to enjoy the opportunity to reach
a bigger and more diverse global audience. By providing an intuitive,
creative and personalized visualization experience, TikTok enables its
community to create and discover tomorrow's trends
Chenyi Qiu, Director of TikTok Operations in West Europe, said: "The rebranding of TikTok in Europe marks a new milestone for us! Through this event we wish to celebrate the diversity of our platform and thus put creativity in the spotlight in different sectors. That is why we approach the theme of sustainable fashion with our community. "
TikTok inspires the best creators and influencers
For the
launch of the new TikTok platform in France, the application paid
tribute to the creativity of its community by organizing original
workshops. To make this moment a memorable evening, TikTok partnered
with the best, and invited creators from different horizons: fashion,
music, dance, makeup, ...
Claire Dartigues, fashion designer and finalist of the 2017 Redress Award, gave a workshop on the importance of sustainable fashion. Claire also inspired her audience by showing them how to create a unique and original outfit entirely made of recyclable materials. During another workshop, TikTok’s influencers and creators unveiled the breadth of their creativity and shared their best tips for creating innovative and creative videos.
Much more than just videos!
With the help of many
influencers including Youtuber Shera
Kerienski
and influencer Estelle
Fitz
, the app unveiled many of the application’s new features.
TikTok presented the "reaction" function
which allows
the user to react directly to their friends’ videos on their phone. This
innovative technology allows users to interact with videos by
integrating their reactions into the content they are viewing. The
platform also unveiled its new
interactive filters made possible by artificial intelligence
,
allowing users to apply filters to their entire body and trigger new
special effects. Rachel
Ward
, famous influencer from TikTok, said : "TikTok is a great app
because it gave me the courage to be myself and have fun the community
is supportive, friendly and diverse."
About TikTok
TikTok is a
destination for short-form mobile videos. Our mission is to capture and
present the world's creativity, knowledge, and moments that matter,
directly from the mobile phone. TikTok enables everyone to be a creator
and encourages users to share their passion and creative expression
through their videos. TikTok is based in Los Angeles, with global
offices in London, Tokyo, Seoul, Shanghai, Beijing, Singapore, Jakarta,
Mumbai, and Moscow. In early 2018, TikTok was one of the most downloaded
apps in the world. TikTok is available worldwide for iOS
and Android
. Visit tiktok.com
.
1 Sensor tower, 1Q report
View source version on businesswire.com: https://www.businesswire.com/news/home/20180906005390/en/
Contact:
Agence Burson Cohn&Wolfe Giulia Goodwin - Charlotte Durand tiktokfr@cohnwolfe.com +33 (0)1 56 03 13 83 / +33 (0)6 28 79 11 40 +33 1 56 03 13 66
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom